Pancreastatin, porcine

CAS No. 106477-83-2

Pancreastatin, porcine( ——— )

Catalog No. M41487 CAS No. 106477-83-2

Pancreastatin (swine) is a49-residue peptide which strongly inhibits glucose-induced insulin release. Pancreastatin (swine) can be isolated and characterized from porcine pancreas.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 514 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Pancreastatin, porcine
  • Note
    Research use only, not for human use.
  • Brief Description
    Pancreastatin (swine) is a49-residue peptide which strongly inhibits glucose-induced insulin release. Pancreastatin (swine) can be isolated and characterized from porcine pancreas.
  • Description
    Pancreastatin (swine) is a49-residue peptide which strongly inhibits glucose-induced insulin release. Pancreastatin (swine) can be isolated and characterized from porcine pancreas.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    106477-83-2
  • Formula Weight
    5103.4
  • Molecular Formula
    C214H330N68O76S
  • Purity
    >98% (HPLC)
  • Solubility
    H2O : ≥ 100 mg/mL (19.59 mM)
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tatemoto K, et al. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature. 1986 Dec 4-10;324(6096):476-8.?
molnova catalog
related products
  • Incensole acetate

    Incensole acetate is a novel anti-inflammatory compound that inhibits NF-κB activation.

  • 16 alpha-Hydroxytram...

    16 alpha-Hydroxytrametenolic acid can inhibit 12-O-tetradecanoylphorbol 13-acetate (TAP)-induced mouse ear edema.

  • Cyclosporine

    Cyclosporine is a calcineurin phosphatase pathway inhibitor, used as an immunosuppressant drug to prevent rejection in organ transplantation.